CLINICAL_TRIALS
trial_result
· 2022-04-27
Clinical Trial Update: Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension [Phase 4]
Summary
Phase 4 trial update evaluating intramuscular phenylephrine HCL to prevent spinal anesthesia-induced hypotension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rehman Medical Institute - RMI | Conditions: Hypotension, Anesthesia | Phase 4 | Status: COMPLETED